<HTML lang="en" dir="ltr" class="client-nojs">
<style type="text/css">
A:before { content:' '; } 
A:after { content:' '; } 
SPAN:before { content:' '; } 
SPAN:after { content:' '; } 
</style>
<BODY class="mediawiki ltr sitedir-ltr ns-0 ns-subject page-Team_NUDT_CHINA_Practices skin-igem action-view"><DIV id="globalWrapper"><DIV id="content" class="mw-body" role="main"><H1 id="firstHeading" class="firstHeading"><SPAN dir="auto">Team:NUDT CHINA//Practices</SPAN></H1><DIV id="bodyContent"><DIV id="mw-content-text" lang="en" dir="ltr" class="mw-content-ltr"><P>&lt;!DOCTYPE html&gt;</P><DIV id="myMainContainer"><DIV id="menu"><LI><A id="HOME" href="https://2015.igem.org/Team:NUDT_CHINA"><SPAN>HOME</SPAN></A></LI><LI><A id="PROJECT" href="#"><SPAN>PROJECT</SPAN></A></LI><LI><A id="Description" href="https://2015.igem.org/Team:NUDT_CHINA/Description" class="b"><SPAN>Description</SPAN></A></LI><LI><A id="Experiments" href="https://2015.igem.org/Team:NUDT_CHINA/Experiments" class="b"><SPAN>Experiments &amp; Protocols</SPAN></A></LI><LI><A id="Results" href="https://2015.igem.org/Team:NUDT_CHINA/Results" class="b"><SPAN>Results</SPAN></A></LI><LI><A id="Design" href="https://2015.igem.org/Team:NUDT_CHINA/Design" class="b"><SPAN>Design</SPAN></A></LI><LI><A id="PARTS" href="#"><SPAN>PARTS</SPAN></A></LI><LI><A id="Team" href="https://2015.igem.org/Team:NUDT_CHINA/Parts" class="b"><SPAN>Team Parts</SPAN></A></LI><LI><A id="Basic" href="https://2015.igem.org/Team:NUDT_CHINA/Basic_Part" class="b"><SPAN>Basic Parts</SPAN></A></LI><LI><A id="Composite" href="https://2015.igem.org/Team:NUDT_CHINA/Composite_Part" class="b"><SPAN>Composite Parts</SPAN></A></LI><LI><A id="NOTEBOOK" href="https://2015.igem.org/Team:NUDT_CHINA/Notebook"><SPAN>NOTEBOOK</SPAN></A></LI><LI><A id="ATTRIBUTIONS" href="https://2015.igem.org/Team:NUDT_CHINA/Attributions"><SPAN>ATTRIBUTIONS</SPAN></A></LI><LI><A id="COLLABORATIONS" href="https://2015.igem.org/Team:NUDT_CHINA/Collaborations"><SPAN>COLLABORATIONS</SPAN></A></LI><LI><A id="HUMAN" href="https://2015.igem.org/Team:NUDT_CHINA/Practices"><SPAN>HUMAN PRACTICES</SPAN></A></LI><LI><A id="SAFETY" href="https://2015.igem.org/Team:NUDT_CHINA/Safety"><SPAN>SAFETY</SPAN></A></LI><LI><A id="MODELING" href="https://2015.igem.org/Team:NUDT_CHINA/Modeling"><SPAN>MODELING</SPAN></A></LI><LI><A id="MEASUREMENT" href="https://2015.igem.org/Team:NUDT_CHINA/Measurement"><SPAN>MEASUREMENT</SPAN></A></LI><LI><A id="ENTREPRENEURSHIP" href="https://2015.igem.org/Team:NUDT_CHINA/Entrepreneurship"><SPAN>ENTREPRENEURSHIP</SPAN></A></LI></DIV><DIV id="NUDT_Container" class="clearStyle"><P style="font-size: 12px;">TIPS: Click <B style="color: #000000">SUBTITLE</B> to fold or unfold the content.</P><H1>HUMAN PRACTICES</H1><H2 id="pos1">INTERVIEW: Human Laboratory Animal Center</H2><DIV class="BLANK_Container" id="slide1"><H3>I.PREFACE</H3><P>Considering our project may have an impact on the biopharmaceutical field to a certain extent, especially on the efficiency of the production of drug, we interviewed Hunan Laboratory Animal Center (HLAC) for some advice on safety and prospect. </P><H3>II.PARTICIPANTS</H3><CENTER><TABLE><TBODY><TR><TD style="font-size: 10px;">Interviewers and Interviewee</TD></TR></TBODY></TABLE><TABLE><TBODY><TR><TD style="font-size: 10px;"><B>Doctor</B> Jiang</TD><TD style="font-size: 10px;"><B>Instructor</B> Lingyun Zhu</TD><TD style="font-size: 10px;"><B>Student</B> Dongyu Fan</TD><TD style="font-size: 10px;"><B>Student</B> Yizhong Wang</TD></TR></TBODY></TABLE></CENTER><H3>III.SPOT</H3><CENTER><TABLE><TBODY><TR><TD style="font-size: 10px;">Human Laboratory Animal Center</TD></TR></TBODY></TABLE></CENTER><H3>IV.DIALOGUE</H3><DIV id="NUDT_Dia_Container"><SECTION style="border: 0px; margin: 0.2em 0px; box-sizing: border-box; padding: 0px;"><SECTION style="display: inline-block; width: 80px; vertical-align: top; box-sizing: border-box;"><SECTION style="font-size: 0.8em; font-family: inherit; text-align: center; text-decoration: inherit; color: inherit; box-sizing: border-box;"><SECTION style="box-sizing: border-box;">Dongyu Fan
		                    </SECTION></SECTION></SECTION><SECTION style="display: inline-block; width: 75%; font-size: 87.5%; font-family: inherit; text-decoration: inherit; color: inherit; border-color: #ffe4c8; box-sizing: border-box;"><SECTION style="display: inline-block; width: 85%; margin-top: 11px; padding: 16px; border-top-left-radius: 16px; border-top-right-radius: 16px; border-bottom-right-radius: 16px; border-bottom-left-radius: 16px; background-color: #ffe4c8; box-sizing: border-box;"><SECTION style="box-sizing: border-box;">Moring Dr. Jiang, thank you for accept our interview. We all know that, in recent years, bio-pharmaceutical security has been subject to the general interest. We've learned that the Experimental Animal Center are already passed the identification of United States AAALAC Certification Center on safety evaluation of drugs. So we hope we can gain an objective and comprehensive assessment of our project and are eager for valuable advice through this interview.</SECTION></SECTION></SECTION></SECTION><SECTION style="border: 0px; margin: 0.2em 0px; box-sizing: border-box; padding: 0px;"><SECTION style="display: inline-block; width: 80px; vertical-align: top; box-sizing: border-box;"><SECTION style="font-size: 0.8em; font-family: inherit; text-align: center; text-decoration: inherit; color: inherit; box-sizing: border-box;"><SECTION style="box-sizing: border-box;">Lingyun Zhu
		                    </SECTION></SECTION></SECTION><SECTION style="display: inline-block; width: 75%; font-size: 87.5%; font-family: inherit; text-decoration: inherit; color: inherit; border-color: #a5a5a5; box-sizing: border-box;"><SECTION style="display: inline-block; width: 85%; margin-top: 11px; padding: 16px; border-top-left-radius: 16px; border-top-right-radius: 16px; border-bottom-right-radius: 16px; border-bottom-left-radius: 16px; background-color: #a5a5a5; box-sizing: border-box;"><SECTION style="box-sizing: border-box;">Moring Dr. Jiang! First of all, I would like to introduce our project. What we are actually doing is using synthetic biology to build a DNA support system. This system is in microorganisms so that we can increase efficiency of regionalization reaction through metabolic engineering of multi-enzymatic reaction.</SECTION></SECTION></SECTION></SECTION><SECTION style="border: 0px; text-align: right; margin: 0.2em 0px; box-sizing: border-box; padding: 0px;"><SECTION style="display: inline-block; width: 75%; font-size: 87.5%; font-family: inherit; text-decoration: inherit; color: inherit; border-color: #7be8cd; box-sizing: border-box;"><SECTION style="display: inline-block; width: 85%; margin-top: 11px; padding: 16px; border-top-left-radius: 16px; border-top-right-radius: 16px; border-bottom-right-radius: 16px; border-bottom-left-radius: 16px; text-align: left; background-color: #7be8cd; box-sizing: border-box;"><SECTION style="box-sizing: border-box;">As far as I understand, metabolic engineering is similar with biochemical reactions.</SECTION></SECTION></SECTION><SECTION style="display: inline-block; vertical-align: top; width: 80px; box-sizing: border-box;"><SECTION style="font-size: 0.8em; font-family: inherit; text-align: center; text-decoration: inherit; color: inherit; box-sizing: border-box;"><SECTION style="box-sizing: border-box;">Dr. Jiang</SECTION></SECTION></SECTION></SECTION><SECTION style="border: 0px; margin: 0.2em 0px; box-sizing: border-box; padding: 0px;"><SECTION style="display: inline-block; width: 80px; vertical-align: top; box-sizing: border-box;"><SECTION style="font-size: 0.8em; font-family: inherit; text-align: center; text-decoration: inherit; color: inherit; box-sizing: border-box;"><SECTION style="box-sizing: border-box;">Dongyu Fan
		                    </SECTION></SECTION></SECTION><SECTION style="display: inline-block; width: 75%; font-size: 87.5%; font-family: inherit; text-decoration: inherit; color: inherit; border-color: #ffe4c8; box-sizing: border-box;"><SECTION style="display: inline-block; width: 85%; margin-top: 11px; padding: 16px; border-top-left-radius: 16px; border-top-right-radius: 16px; border-bottom-right-radius: 16px; border-bottom-left-radius: 16px; background-color: #ffe4c8; box-sizing: border-box;"><SECTION style="box-sizing: border-box;">Could you evaluate the safety of our reconstruction project of the microbial?</SECTION></SECTION></SECTION></SECTION><SECTION style="border: 0px; text-align: right; margin: 0.2em 0px; box-sizing: border-box; padding: 0px;"><SECTION style="display: inline-block; width: 75%; font-size: 87.5%; font-family: inherit; text-decoration: inherit; color: inherit; border-color: #7be8cd; box-sizing: border-box;"><SECTION style="display: inline-block; width: 85%; margin-top: 11px; padding: 16px; border-top-left-radius: 16px; border-top-right-radius: 16px; border-bottom-right-radius: 16px; border-bottom-left-radius: 16px; text-align: left; background-color: #7be8cd; box-sizing: border-box;"><SECTION style="box-sizing: border-box;">Our security assessment is mainly for drugs, such as the safety of medicines produced by the bioactive enzymes, which means we need a specific bioactive substance such as enzymes to conduct the safety assessment. Your project is more like a methodology study which does not have direct relation to medicine, so I can only make a safety assessment of potential safety hazard instead of a detailed one.</SECTION></SECTION></SECTION><SECTION style="display: inline-block; vertical-align: top; width: 80px; box-sizing: border-box;"><SECTION style="font-size: 0.8em; font-family: inherit; text-align: center; text-decoration: inherit; color: inherit; box-sizing: border-box;"><SECTION style="box-sizing: border-box;">Dr. Jiang</SECTION></SECTION></SECTION></SECTION><SECTION style="border: 0px; margin: 0.2em 0px; box-sizing: border-box; padding: 0px;"><SECTION style="display: inline-block; width: 80px; vertical-align: top; box-sizing: border-box;"><SECTION style="font-size: 0.8em; font-family: inherit; text-align: center; text-decoration: inherit; color: inherit; box-sizing: border-box;"><SECTION style="box-sizing: border-box;">Dongyu Fan
		                    </SECTION></SECTION></SECTION><SECTION style="display: inline-block; width: 75%; font-size: 87.5%; font-family: inherit; text-decoration: inherit; color: inherit; border-color: #ffe4c8; box-sizing: border-box;"><SECTION style="display: inline-block; width: 85%; margin-top: 11px; padding: 16px; border-top-left-radius: 16px; border-top-right-radius: 16px; border-bottom-right-radius: 16px; border-bottom-left-radius: 16px; background-color: #ffe4c8; box-sizing: border-box;"><SECTION style="box-sizing: border-box;">What influence will be make to the cells if we change the signaling pathways of cell?</SECTION></SECTION></SECTION></SECTION><SECTION style="border: 0px; text-align: right; margin: 0.2em 0px; box-sizing: border-box; padding: 0px;"><SECTION style="display: inline-block; width: 75%; font-size: 87.5%; font-family: inherit; text-decoration: inherit; color: inherit; border-color: #7be8cd; box-sizing: border-box;"><SECTION style="display: inline-block; width: 85%; margin-top: 11px; padding: 16px; border-top-left-radius: 16px; border-top-right-radius: 16px; border-bottom-right-radius: 16px; border-bottom-left-radius: 16px; text-align: left; background-color: #7be8cd; box-sizing: border-box;"><SECTION style="box-sizing: border-box;">The level of the cell modification plays an important role in drug safety. Generally speaking, lower modification level means less side effects. Modification of subcellular structure may cause the cell activity change. If it leads to an acceleration of cell metabolism, it may eventually make the cell cancerous or autophagy.</SECTION></SECTION></SECTION><SECTION style="display: inline-block; vertical-align: top; width: 80px; box-sizing: border-box;"><SECTION style="font-size: 0.8em; font-family: inherit; text-align: center; text-decoration: inherit; color: inherit; box-sizing: border-box;"><SECTION style="box-sizing: border-box;">Dr. Jiang</SECTION></SECTION></SECTION></SECTION><SECTION style="border: 0px; margin: 0.2em 0px; box-sizing: border-box; padding: 0px;"><SECTION style="display: inline-block; width: 80px; vertical-align: top; box-sizing: border-box;"><SECTION style="font-size: 0.8em; font-family: inherit; text-align: center; text-decoration: inherit; color: inherit; box-sizing: border-box;"><SECTION style="box-sizing: border-box;">Dongyu Fan
		                    </SECTION></SECTION></SECTION><SECTION style="display: inline-block; width: 75%; font-size: 87.5%; font-family: inherit; text-decoration: inherit; color: inherit; border-color: #ffe4c8; box-sizing: border-box;"><SECTION style="display: inline-block; width: 85%; margin-top: 11px; padding: 16px; border-top-left-radius: 16px; border-top-right-radius: 16px; border-bottom-right-radius: 16px; border-bottom-left-radius: 16px; background-color: #ffe4c8; box-sizing: border-box;"><SECTION style="box-sizing: border-box;">What kind of side effects?</SECTION></SECTION></SECTION></SECTION><SECTION style="border: 0px; text-align: right; margin: 0.2em 0px; box-sizing: border-box; padding: 0px;"><SECTION style="display: inline-block; width: 75%; font-size: 87.5%; font-family: inherit; text-decoration: inherit; color: inherit; border-color: #7be8cd; box-sizing: border-box;"><SECTION style="display: inline-block; width: 85%; margin-top: 11px; padding: 16px; border-top-left-radius: 16px; border-top-right-radius: 16px; border-bottom-right-radius: 16px; border-bottom-left-radius: 16px; text-align: left; background-color: #7be8cd; box-sizing: border-box;"><SECTION style="box-sizing: border-box;">Increasing reaction rate may result an accumulation of intermediate products which cause side effects. However, your project will not only increase the reaction efficiency but also make the reaction ordered. This modification of reaction chain makes reaction under control. In other word, the type and output of productions can be controlled. Theoretically, the side effects can be minimized.</SECTION></SECTION></SECTION><SECTION style="display: inline-block; vertical-align: top; width: 80px; box-sizing: border-box;"><SECTION style="font-size: 0.8em; font-family: inherit; text-align: center; text-decoration: inherit; color: inherit; box-sizing: border-box;"><SECTION style="box-sizing: border-box;">Dr. Jiang</SECTION></SECTION></SECTION></SECTION><SECTION style="border: 0px; margin: 0.2em 0px; box-sizing: border-box; padding: 0px;"><SECTION style="display: inline-block; width: 80px; vertical-align: top; box-sizing: border-box;"><SECTION style="font-size: 0.8em; font-family: inherit; text-align: center; text-decoration: inherit; color: inherit; box-sizing: border-box;"><SECTION style="box-sizing: border-box;">Dongyu Fan
		                    </SECTION></SECTION></SECTION><SECTION style="display: inline-block; width: 75%; font-size: 87.5%; font-family: inherit; text-decoration: inherit; color: inherit; border-color: #ffe4c8; box-sizing: border-box;"><SECTION style="display: inline-block; width: 85%; margin-top: 11px; padding: 16px; border-top-left-radius: 16px; border-top-right-radius: 16px; border-bottom-right-radius: 16px; border-bottom-left-radius: 16px; background-color: #ffe4c8; box-sizing: border-box;"><SECTION style="box-sizing: border-box;">Finally, could you please make a prospection of our project?</SECTION></SECTION></SECTION></SECTION><SECTION style="border: 0px; text-align: right; margin: 0.2em 0px; box-sizing: border-box; padding: 0px;"><SECTION style="display: inline-block; width: 75%; font-size: 87.5%; font-family: inherit; text-decoration: inherit; color: inherit; border-color: #7be8cd; box-sizing: border-box;"><SECTION style="display: inline-block; width: 85%; margin-top: 11px; padding: 16px; border-top-left-radius: 16px; border-top-right-radius: 16px; border-bottom-right-radius: 16px; border-bottom-left-radius: 16px; text-align: left; background-color: #7be8cd; box-sizing: border-box;"><SECTION style="box-sizing: border-box;">I have engaged in drug safety assessment many years. I think what restricts the development of the pharmaceutical industry is the disorder of reaction. The disorder makes it difficult to get the identical ingredients in different production batch which cause worse side effects. Your project is supposed to order the reaction chain and decrease the impure component of drug. This can not only increase the reaction rate but also improve the quality of drugs. I believe it will have a positive influence on the development of the pharmaceutical industry. </SECTION></SECTION></SECTION><SECTION style="display: inline-block; vertical-align: top; width: 80px; box-sizing: border-box;"><SECTION style="font-size: 0.8em; font-family: inherit; text-align: center; text-decoration: inherit; color: inherit; box-sizing: border-box;"><SECTION style="box-sizing: border-box;">Dr. Jiang</SECTION></SECTION></SECTION></SECTION><SECTION style="border: 0px; margin: 0.2em 0px; box-sizing: border-box; padding: 0px;"><SECTION style="display: inline-block; width: 80px; vertical-align: top; box-sizing: border-box;"><SECTION style="font-size: 0.8em; font-family: inherit; text-align: center; text-decoration: inherit; color: inherit; box-sizing: border-box;"><SECTION style="box-sizing: border-box;">Dongyu Fan
		                    </SECTION></SECTION></SECTION><SECTION style="display: inline-block; width: 75%; font-size: 87.5%; font-family: inherit; text-decoration: inherit; color: inherit; border-color: #ffe4c8; box-sizing: border-box;"><SECTION style="display: inline-block; width: 85%; margin-top: 11px; padding: 16px; border-top-left-radius: 16px; border-top-right-radius: 16px; border-bottom-right-radius: 16px; border-bottom-left-radius: 16px; background-color: #ffe4c8; box-sizing: border-box;"><SECTION style="box-sizing: border-box;">Thanks for your answer.</SECTION></SECTION></SECTION></SECTION></DIV></DIV></DIV><DIV id="navigation"><LI><A href="#mainContainer" class="t"><SPAN>TOP</SPAN></A></LI><LI><A href="#pos1"><SPAN>INTERVIEW</SPAN></A></LI><LI><A href="#pos2"><SPAN>Title 2</SPAN></A></LI><LI><A href="#pos2" class="b"><SPAN>Title 2.1</SPAN></A></LI><LI><A href="#pos3" class="b"><SPAN>Title 2.2</SPAN></A></LI><LI><A href="#pos4"><SPAN>Title 3</SPAN></A></LI><LI><A href="#pos4" class="b"><SPAN>Title 3.1</SPAN></A></LI><LI><A href="#pos5"><SPAN>Title 4</SPAN></A></LI><LI><A href="#pos6"><SPAN>Title 5</SPAN></A></LI></DIV></DIV></DIV></DIV></DIV></DIV></BODY></HTML>